Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Buprenorphine Buccal Film [Belbuca]

Phase 1

NNatasha Archer

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Sickle Cell Disease (SCD)Not yet recruiting

Sickle Cell Disease (SCD)Phase 1

Not yet recruiting

Timeline

Expected Milestones

Q4 2032

Phase 1Not yet recruiting

Sickle Cell Disease (SCD)

NCT07799571

Clinical

Trials by Indication[1]

Sickle Cell Disease (SCD)1 trial

Buprenorphine for the Management of Pain in Children With Sickle Cell Disease

Not yet recruiting·NNatasha Archer·Phase 1·NCT07799571·25 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Buprenorphine Buccal Film [Belbuca]. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Buprenorphine Buccal Film [Belbuca]. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Natasha Archer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 1[1]
Company: NNatasha Archer

Related News